stoxline Quote Chart Rank Option Currency Glossary
  
IRIDEX Corporation (IRIX)
2  -0.16 (-7.41%)    07-17 16:00
Open: 2.15
High: 2.27
Volume: 29,308
  
Pre. Close: 2.16
Low: 2
Market Cap: 33(M)
Technical analysis
2024-07-17 5:28:14 PM
Short term     
Mid term     
Targets 6-month :  2.58 1-year :  2.81
Resists First :  2.21 Second :  2.4
Pivot price 2.08
Supports First :  1.88 Second :  1.57
MAs MA(5) :  2.09 MA(20) :  2.08
MA(100) :  2.58 MA(250) :  2.47
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  30.6 D(3) :  37.2
RSI RSI(14): 39.8
52-week High :  3.65 Low :  1.3
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ IRIX ] has closed above bottom band by 19.0%. Bollinger Bands are 52.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.27 - 2.28 2.28 - 2.29
Low: 1.98 - 1.99 1.99 - 2
Close: 1.98 - 2 2 - 2.02
Company Description

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Headline News

Wed, 17 Jul 2024
IRIDEX Co. (NASDAQ:IRIX) Short Interest Update - Defense World

Tue, 16 Jul 2024
Head-To-Head Survey: QT Imaging (NASDAQ:QTI) versus IRIDEX (NASDAQ:IRIX) - American Banking and Market News

Tue, 14 May 2024
Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth? - Simply Wall St

Tue, 14 May 2024
Iridex Reports First Quarter 2024 Financial Results - Yahoo Finance

Wed, 08 May 2024
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024 - Yahoo Finance

Thu, 28 Mar 2024
Iridex's Strategic Review Process Should Bear Fruit "Soon" (NASDAQ:IRIX) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 16 (M)
Shares Float 12 (M)
Held by Insiders 20 (%)
Held by Institutions 20.4 (%)
Shares Short 318 (K)
Shares Short P.Month 318 (K)
Stock Financials
EPS -0.68
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.4
Profit Margin -22 %
Operating Margin -28 %
Return on Assets (ttm) -18.3 %
Return on Equity (ttm) -97.9 %
Qtrly Rev. Growth -14.2 %
Gross Profit (p.s.) 0
Sales Per Share 3.07
EBITDA (p.s.) -0.63
Qtrly Earnings Growth 0 %
Operating Cash Flow -6 (M)
Levered Free Cash Flow 1 (M)
Stock Valuations
PE Ratio -2.99
PEG Ratio -0.2
Price to Book value 5
Price to Sales 0.65
Price to Cash Flow -5.86
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android